Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2008-07-01
2008-07-01
Helms, Larry R. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S300000, C530S828000, C424S185100, C424S277100
Reexamination Certificate
active
09729653
ABSTRACT:
The present invention relates to novel prostate specific nucleic acid molecules and polypeptides and related methods for diagnosing or predicting susceptibility to a prostate neoplastic condition.
REFERENCES:
patent: 5861248 (1999-01-01), Russell et al.
patent: WO 00/65067 (2000-11-01), None
Jansen, M et al, 1995, Pediatric Res, 37 (6): 681-686.
Alberts et al. Molecular Biology of the Cell, 3rd edition, 1994, p. 465.
Shantz and Pegg. Int J of Biochem and Cell Biol., 1999, vol. 31, pp. 107-122.
McClean and Hill. Eur J of Cancer, 1993, vol. 29A, pp. 2243-2248.
Fu et al. EMBO Journal, 1996, vol. 15, pp. 4392-4401.
Yokota, J et al (Oncogene, 1988,vol. 3, pp. 471-475.
Gelmini S et al, 2001, Clin Chem Lab Med, 39(5): 385-91.
Kibel, AS et al, 2000, J urol, 164(1): 192-6.
Ren, C et al, 1998, Cancer Res, 58(6): 1285-90.
Gingrich, JR et al, 1996, Cancer res, 56(18): 4096-4102.
Burgess et al. Journal of Cell Biology, 1990, 11: 2129-2138.
Lazar et al. Molecular and Cell Biology, 1988, 8: 1247-1252.
Tao. et al. The Journal of Immunology, 1989, 143(8): 2595-2601.
Gillies et al. Human Antibodies and Hybridomas, 1990, 1(1): 47-54.
Nagase T et al, 2000, Genbank Sequence Database (Accession No. Q9HCD4 ) and MPSRCH search report, 2002, us-09-729653-2.rspt, pp. 1-2.
Kawakami T et al, 2000, Genbank Sequence Database (Accession No. Q9H5S0) and MPSRCH search report, 2002, us-09-729653-2.rspt, p. 3.
Steward, C A, 1998, Genbank Sequence Database (Accession No. 046018 ), and MPSRCH search report, 2002, us-09-729653-2.rspt, p. 4.
Drexler et al. Leukemia and Lymphoma, 1993, 9:1-25.
Embleton et al. Immunol Ser, 1984, 23:181-207.
Hsu : In Tissue Culture Methods and Applications, Kruse and Patterson, Eds, 1973, Academic Press, NY, see abstract, p. 764.
Freshney. Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4.
Dermer (Bio/Technology, 1994, 12:320.
Schmid S et al, 2001, J comparative Neurology, 430(2): 160-71.
Conner et al, 1996, Mol Brain Res, 42: 1-17.
Bowie (Science, 1990, 257:1306-1310).
GenBank Accession No. AA363808: EST4273 Pancreas IIHomo sapienscDNA 5′ end, mRNA sequence.
GenBank Accession No. AAF57545: CG11237 Gene product [Drosophila melanogaster].
GenBank Accession No. AB046858:Homo sapiensmRNA for KIAA1638 protein, partial cds.
GenBank Accession No. AK026780:Homo sapienscDNA: FLJ23127 fis, clone LNG08350.
GenBank Accession No. AW959484: EST371554 MAGE resequences, MAGFHomo sapienscDNA, mRNA sequence.
GenBank Accession No. BE165930: MR3-HTO487-290100-103-f03 HT0487Homo sapienscDNA, mRNA sequence.
GenBank Accession No. BE893201: 601436910F1 NIH—MGC—72Homo sapienscDNA clone Image:3921746 5′, mRNA sequence.
GenBank Accession No. T27880: Hypothetical protein ZK520.1—Caenorhabditis elegans.
GenBank Accession No. CAB07299: ZK520.1 [Caenorhabditis elegans].
GenBank Accession No. CAB07301: ZK520.3 [Caenorhabditis elegans].
GenBank Accession Nno. Z92822:Caenorhabditis eleganscosmid ZK520, complete sequence.
Deguchi et al., “Micrometastasis of prostate cancer to lymph nodes: detection by means of reverse transcription-polymerase chain reaction,”J. Natl. Cancer Inst.89:1471-1473 (1997).
Ficazzola and Taneja, “Prospects for gene therapy in human prostate cancer,”Mol. Med. Today4:494-504 (1998).
Kahn et al., “Radioimmunoscintigraphy with111indium labeled CYT-356 for the detection of occult prostate cancer recurrence,”Journal of Urology152:1490-1495 (1994).
Narod, “Genetic epidemiology of prostate cancer,”Biochim. Biophys. Acta.1423:F1-13 (1999).
Neal et al., “Unanswered questions in screening for prostate cancer,”Eur. J. Cancer36:1316-1321 (2000).
Nupponen and Visakorpi, “Molecular biology of progression of prostate cancer,”Eur. Urol.35:351-354 (1999).
Small, “Advances in prostate cancer,”Curr. Opin. Oncol.11:226-235 (1999).
Small and Reese, “An update on prostate cancer research,”Curr. Opin. Oncol.12:265-272 (2000).
Ablin, “A retrospective and prospective overview of prostate-specific antigen,”J. Cancer Res. Clin. Oncol.123:583-594 (1997).
Blok et al., “Isolation of cDNAs that are differentially expressed between androgen-dependent and androgen-independent prostate carcinoma cells using differential display PCR,”The Prostate26:213-224 (1995).
Bussemakers et al., “DD3: A New prostate-specific gene, highly overexpressed in prostate cancer,”Cancer Research59:5975-5979 (1999).
Nelson et al., “An expressed-sequence-tag database of the human prostate: sequence analysis of 1168 cDNA clones,”Genomics47:12-25 (1998).
Srikantan et al., “PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer,”Proc. Natl. Acad. Sci. USA97:12216-12221 (2000).
Vasmatzis et al., “Discovery of three genes specifically expressed in human protstate by expressed sequence tag database analysis,”Proc. Natl. Acad. Sci. USA95:300-304 (1998).
GenBank Accession No.: AW629941.
Davis Minh-Tam
Institute for Systems Biology
LandOfFree
Prostate-specific polypeptide pamp and encoding nucleic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostate-specific polypeptide pamp and encoding nucleic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate-specific polypeptide pamp and encoding nucleic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3911490